Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2022-12-23

MECHANISM OF ACTION OF POLYENE ANTIBIOTICS IN VITRO STUDIES FOR THE IMPROVEMENT OF THE THERAPEUTIC INDEX AGAINST LEISHMANIASIS

Obiettivo


Leishmania are obligate intracellular parasites that cause a spectrum of diseases called leishmaniasis ranging from self healing skin ulcers to a fatal visceral infection. Only a few drugs are available for treatment of leishmaniasis and consequently, there is a need for new drugs. Among them the polyene antibiotic Amphotericin B (AmB) can be useful in the treatment of visceral and mucosal leishmaniasis, and is the most common drug for the treatment of fungal diseases.
This research project is to determine whether the liposomal formulations proposed for fungal diseases can be applied to leishmaniasis and, if so, whether they can be improved. AmB is generally assumed to act at the plasma membrane level of the parasite, by perturbing the membrane permeability. The study will determine the binding of AmB to plasma membranes of Leishmania in promastigote or amastigote form, or macrophages or tubular renal cells, and its consequences for the transmembrane permeability and the viability of the cells.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Programma(i)

Argomento(i)

Dati non disponibili

Invito a presentare proposte

Dati non disponibili

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

UNIVERSITE PIERRE ET MARIE CURIE - PARIS VI
Contributo UE
Nessun dato
Indirizzo
Place Jussieu 4
75252 PARIS
Francia
Costo totale
Nessun dato

Partecipanti (1)